Insmed (INSM) Tops Q1 EPS by 20c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $98.61 --0%
EPS Growth %: +52.9%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +52.9%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.76), $0.20 better than the analyst estimate of ($0.96). Revenue for the quarter came in at $305.96 million versus the consensus estimate of $301.51 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Xcel Energy (XEL) PT Lowered to $91 at Mizuho
- Accenture plc (ACN) PT Lowered to $226 at Mizuho
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
